Tizanidne Hydrochloride Capsule
Product Images NDC 68788-8798

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidne Hydrochloride (NDC 68788-8798). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tiz01 (Tiz01)

Chemical structure of tizanidine hydrochloride. The diagram shows the molecular arrangement including chlorine (Cl), nitrogen (N), sulfur (S), and hydrogen atoms in the tizanidine hydrochloride molecule.*

FDA Label Image

Tiz02 (Tiz02)

A line graph depicting plasma Tizanidine hydrochloride concentration (ng/mL) over time (hours) after dosing. The graph compares 4 mg Tizanidine tablets and capsules taken with and without food, showing concentration changes during a 24-hour period post-dose.*

FDA Label Image

Tiz03 (Tiz03)

A line graph comparing the improvement in Ashworth Score over 6 hours post-dose for 16 mg tizanidine, 8 mg tizanidine, and placebo groups. The y-axis shows improvement scores, while the x-axis shows hours post-dose, demonstrating different levels of effect from the doses and placebo over time.*

FDA Label Image

Tiz04 (Tiz04)

A line graph depicting improvement in Ashworth Score over time for tizanidine (mean dose 28.8 mg) and placebo groups. Data points with error bars are shown at End of Titration (Study Week 3), End of Maintenance (Study Week 7), and Endpoint (Last Observation Carried Forward), illustrating greater improvement for tizanidine compared to placebo.*

FDA Label Image

Tizanidine Hydrochloride Capsules 4mg (Tiz08new 1)

Label for Tizanidine Hydrochloride Capsules 4 mg, a generic for Zanaflex, manufactured by Alkem Laboratories Ltd. The label includes dosage strength, a caution regarding transfer of the drug, storage instructions, and space for batch and lot numbers. The labeler's logo, Preferred Pharmaceuticals Inc., is displayed with an address in Anaheim, CA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.